Author Correction: MiR-488 inhibits proliferation and cisplatin sensibility in non-small-cell lung cancer (NSCLC) cells by activating the eIF3a-mediated NER signaling pathway.
作者信息
Fang Chao, Chen Yi-Xin, Wu Na-Yiyuan, Yin Ji-Ye, Li Xiang-Ping, Huang Hsuan-Shun, Zhang Wei, Zhou Hong-Hao, Liu Zhao-Qian
机构信息
Departments of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, 410008, P. R. China.
Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, 410078, P. R. China.
出版信息
Sci Rep. 2021 Nov 11;11(1):22452. doi: 10.1038/s41598-021-01417-w.
Abstract
摘要
Zotero 插件